Renée Galá

Renée Galá

Chief Executive Officer at JAZZ PHARMACEUTICALS PLC

Net worth: 34 M $ as of 29/09/2026

54 year
Health Technology
Consumer Services
Distribution Services

Profile

Currently, Renée D. Galá occupies the position of Chief Financial Officer & Executive Vice President of Jazz Pharmaceuticals Plc. She is also on the board of Gossamer Bio, Inc. and Gyroscope Therapeutics Ltd. In the past she held the position of Chief Financial Officer, Treasurer & Senior VP at Theravance Biopharma, Inc., Chief Financial Officer at GRAIL, Inc., Vice President-Finance for Innoviva, Inc. and Principal at Eli Lilly & Company (Ireland) Ltd. Renée D. Galá received an undergraduate degree from Vanderbilt University and an MBA from Columbia Business School.

Known holdings in public companies

CompanyDateNumber of sharesValuationValuation date
05/10/2026 141,394 ( 0.22% ) 33 M $ 29/09/2026
27/05/2026 12,486 ( 0% ) 1 M $ 29/09/2026

Renée Galá active positions

CompaniesPositionStart
JAZZ PHARMACEUTICALS PLC Chief Executive Officer 10/08/2025
DEXCOM, INC. Director/Board Member 05/03/2025
Chief Executive Officer -
President 31/12/2019

Former positions of Renée Galá

CompaniesPositionEnd
GOSSAMER BIO, INC. Director/Board Member 05/06/2024
GYROSCOPE THERAPEUTICS HOLDINGS PLC Director/Board Member 16/02/2022
Director/Board Member 31/01/2022
GRAIL, INC. Director of Finance/CFO 05/06/2019
CORCEPT THERAPEUTICS INCORPORATED Director/Board Member 31/05/2019
See the detail of Renée Galá's experience

Education of Renée Galá

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

Connections

62

1st degree connections

14

1st degree companies

Male

Female

Members of the board

Executives

Linked companies

Private companies14

Health Technology

Health Technology

Consumer Services

Health Technology

Health Technology

Distribution Services

Health Technology

Health Technology

Health Technology

Consumer Services

Health Technology

Health Technology

Health Technology

Health Technology